// App-Quantinova.ai

509 : Final Results of PUPs A-LONG Study: Evaluating Safety and Efficacy of rFVIIIFc in Previously Untreated Patients with Haemophilia A

Researchers

Presenter

  • Christoph Koenigs

Principal Investigators

  • Margareth C. Ozelo

  • Amy Dunn

  • Roshni Kulkarni

  • Beatrice Nolan

  • Simon A. Brown

  • Raina Liesner

  • Michele Schiavulli

  • Sriya Gunawardena

  • Sutirtha Mukhopadhyay

  • Deepthi Jayawardene

  • Bent Winding

  • Manuel Carcao

Medical Centers

  • Department of Paediatrics and Adolescent Medicine, University Hospital Frankfurt, Frankfurt

  • University of Campinas, Sao Paulo, Brazil

  • Nationwide Children's Hospital, Columbus, OH

  • Michigan State University, Lansing, MI

  • Children's Health Ireland at Crumlin Dublin 2 Ireland

  • Queensland Children’s Hospital, Brisbane, Australia

  • Great Ormond Street Hospital, London, United Kingdom

  • A.O.R.N. Santobono-Pausilipon, Napes, Campania, Italy

  • Sanofi, Waltham, MA.

  • Sanofi, Gent, Belgium

  • Swedish Orphan Biovitrum AB, Stockholm, Sweden

  • Hospital for Sick Children, Toronto, ON, Canada

Locations

  • Germany

  • Brazil

  • United States

  • Ireland

  • Australia

  • United Kingdom

  • Italy

  • Belgium

  • Sweden

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • Recombinant Factor VIII

  • FVIIIFc

  • FVIII

Outcome

  • N/A

Study Design

  • Open Label

  • Multicenteric

Phase

  • III

Study Id's

  • NCT02234323

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved